{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:31:36Z","timestamp":1780086696915,"version":"3.54.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T00:00:00Z","timestamp":1713657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bioactmat.2024.04.023","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T12:54:19Z","timestamp":1717160059000},"page":"612-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Turning foes to friends: Advanced \u201cin situ nanovaccine\u201d with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Ze","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9279-7744","authenticated-orcid":false,"given":"Tong","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-7917","authenticated-orcid":false,"given":"Jinbiao","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2024.04.023_bib1","article-title":"Spatial predictors of immunotherapy response in triple-negative breast cancer","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib2","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1021\/jacs.3c02619","article-title":"c-Myc-Targeting PROTAC based on a TNA-DNA bivalent binder for combination therapy of triple-negative breast cancer","volume":"145","author":"Li","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib5","doi-asserted-by":"crossref","first-page":"29385","DOI":"10.1021\/acsami.8b11723","article-title":"Loading lovastatin into camptothecin-floxuridine conjugate nanocapsules for enhancing anti-metastatic efficacy of cocktail chemotherapy on triple-negative breast cancer","volume":"10","author":"Zhang","year":"2018","journal-title":"Acs Appl. Mater. Inter."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib6","article-title":"Copper-based nanoscale coordination polymers augmented tumor radioimmunotherapy for immunogenic cell death induction and T-cell infiltration","volume":"17","author":"Wang","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib7","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/acs.nanolett.1c03996","article-title":"Apoptotic body-mediated intracellular delivery strategy for enhanced STING activation and improved tumor immunogenicity","volume":"22","author":"Bao","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib8","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1172\/JCI99673","article-title":"\u0394Np63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer","volume":"128","author":"Kumar","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202100014","article-title":"KAT6A acetylation of SMAD3 regulates myeloid-derived suppressor cell recruitment, metastasis, and immunotherapy in triple-negative breast cancer","volume":"8","author":"Yu","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/cdd.2013.72","article-title":"Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists","volume":"21","author":"Yamazaki","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib12","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12951-022-01278-z","article-title":"Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib15","article-title":"Self-splittable transcytosis nanoraspberry for NIR-II photo-immunometabolic cancer therapy in deep tumor tissue","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.actbio.2023.05.014","article-title":"Multifunctional nano-system for multi-mode targeted imaging and enhanced photothermal therapy of metastatic prostate cancer","volume":"166","author":"Wang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib17","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1039\/D2TB00531J","article-title":"AuNCs-LHRHa nano-system for FL\/CT dual-mode imaging and photothermal therapy of targeted prostate cancer","volume":"10","author":"Wang","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib18","first-page":"42","article-title":"Engineering naphthalimide-cyanine integrated near-infrared dye into ROS-responsive nanohybrids for tumor PDT\/PTT\/chemotherapy","volume":"14","author":"Jin","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/acs.nanolett.3c03191","article-title":"Immunoadjuvant-modified potentiate cancer photothermal immunotherapy","volume":"24","author":"Niu","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib20","doi-asserted-by":"crossref","first-page":"23805","DOI":"10.1002\/anie.202109863","article-title":"Aggregation of gold nanoparticles triggered by hydrogen peroxide-initiated chemiluminescence for activated tumor theranostics","volume":"60","author":"Mao","year":"2021","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib21","doi-asserted-by":"crossref","first-page":"20513","DOI":"10.1021\/jacs.1c11242","article-title":"Strain-modulated seeded growth of highly branched black Au superparticles for efficient photothermal conversion","volume":"143","author":"Zhong","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119911","article-title":"Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator","volume":"241","author":"He","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib23","first-page":"239","article-title":"Tumor microenvironment-adaptive nanoplatform synergistically enhances cascaded chemodynamic therapy","volume":"22","author":"Wang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib24","article-title":"Boosting H O -guided chemodynamic therapy of cancer by enhancing reaction kinetics through versatile biomimetic fenton nanocatalysts and the second near-infrared light irradiation","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib25","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1021\/acsabm.1c00832","article-title":"Prospects of exploring the metal-organic framework for combating antimicrobial resistance","volume":"4","author":"Polash","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib26","article-title":"Tumor-microenvironment-activated reactive oxygen species amplifier for enzymatic cascade cancer starvation\/chemodynamic\/immunotherapy","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101397","article-title":"NIR-II laser-mediated photo-Fenton-like reaction plasmonic Cu9S8 for immunotherapy enhancement","volume":"43","author":"An","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib28","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.2c06560","article-title":"Programming of nanovaccines for lymph node-targeted delivery and cancer immunotherapy","author":"Jin","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib29","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1021\/acs.nanolett.2c00500","article-title":"Surgical tumor-derived photothermal nanovaccine for personalized cancer therapy and prevention","volume":"22","author":"Li","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib30","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6071","article-title":"A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer","volume":"6","author":"Ni","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib33","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/acs.biomac.8b01473","article-title":"Impact of polymer-TLR-7\/8 agonist (adjuvant) morphology on the potency and mechanism of CD8 T cell induction","volume":"20","author":"Lynn","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119629","article-title":"Modulation of tumor microenvironment using a TLR-7\/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination","volume":"230","author":"Chen","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115386","article-title":"Pomegranate-inspired multifunctional nanocomposite wound dressing for intelligent self-monitoring and promoting diabetic wound healing","volume":"235","author":"Wang","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib36","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1021\/acscentsci.3c00994","article-title":"One stone, three birds: multifunctional nanodots as \u201cpilot light\u201d for guiding surgery, enhanced radiotherapy, and brachytherapy of tumors","volume":"9","author":"Wang","year":"2023","journal-title":"Acs Central Sci."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biomaterials.2019.03.014","article-title":"Ultrasmall Cu2-XS nanodots as photothermal-enhanced Fenton nanocatalysts for synergistic tumor therapy at NIR-II biowindow","volume":"206","author":"Hu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.04.023_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib40","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib41","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib42","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","article-title":"Metastatic and triple-negative breast cancer: challenges and treatment options","volume":"8","author":"Al-Mahmood","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib43","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3389\/fimmu.2018.02909","article-title":"Immunomodulation of the tumor microenvironment: turn foe into friend","volume":"9","author":"Locy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202360","article-title":"Rhythm mild-temperature photothermal therapy enhancing immunogenic cell death response in oral squamous cell carcinoma","volume":"12","author":"Ran","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2024.04.023_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010147","article-title":"Exposure of immunogenic tumor antigens in surrendered immunity and the significance of autologous tumor cell-based vaccination in precision medicine","volume":"24","author":"Ke","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24001543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24001543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:12:51Z","timestamp":1727968371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24001543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"alternative-id":["S2452199X24001543"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.04.023","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Turning foes to friends: Advanced \u201cin situ nanovaccine\u201d with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}